CIBC Private Wealth Group
REGN icon

CIBC Private Wealth Group’s Regeneron Pharmaceuticals REGN Stock Holding History

CIBC Private Wealth Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.5M Sell
1,943
-170
-8% -$115K ﹤0.01% 640
2025
Q3 		$1.19M Buy
2,113
+143
+7% +$80.9K ﹤0.01% 664
2025
Q2 		$1.03M Sell
1,970
-26
-1% -$14.5K ﹤0.01% 664
2025
Q1 		$1.11M Sell
1,996
-120
-6% -$82.5K ﹤0.01% 632
2024
Q4 		$1.55M Sell
2,116
-436
-17% -$366K ﹤0.01% 610
2024
Q3 		$2.68M Buy
2,552
+312
+14% +$347K ﹤0.01% 513
2024
Q2 		$2.36M Sell
2,240
-71
-3% -$68.8K ﹤0.01% 512
2024
Q1 		$2.24M Sell
2,311
-65
-3% -$61.8K ﹤0.01% 528
2023
Q4 		$2.09M Buy
2,376
+3
+0.1% +$2.47K ﹤0.01% 507
2023
Q3 		$1.95M Buy
2,373
+1,366
+136% +$1.07M ﹤0.01% 496
2023
Q2 		$724K Sell
1,007
-56
-5% -$43.2K ﹤0.01% 638
2023
Q1 		$873K Sell
1,063
-700
-40% -$528K ﹤0.01% 628
2022
Q4 		$1.27M Sell
1,763
-8,150
-82% -$6.01M ﹤0.01% 488
2022
Q3 		$6.83M Sell
9,913
-786
-7% -$495K 0.02% 342
2022
Q2 		$6.32M Sell
10,699
-31
-0.3% -$20.1K 0.02% 350
2022
Q1 		$7.49M Sell
10,730
-321
-3% -$203K 0.02% 358
2021
Q4 		$6.98M Buy
11,051
+1,121
+11% +$689K 0.01% 370
2021
Q3 		$6.01M Sell
9,930
-697
-7% -$433K 0.01% 374
2021
Q2 		$5.94M Sell
10,627
-201
-2% -$102K 0.01% 381
2021
Q1 		$5.12M Sell
10,828
-11,798
-52% -$5.74M 0.01% 395
2020
Q4 		$10.9M Buy
22,626
+1,202
+6% +$649K 0.03% 319
2020
Q3 		$12.1M Buy
21,424
+9,439
+79% +$5.72M 0.04% 271
2020
Q2 		$7.47M Sell
11,985
-9,153
-43% -$5.2M 0.04% 269
2020
Q1 		$10.3M Buy
21,138
+2,590
+14% +$1.07M 0.04% 248
2019
Q4 		$6.96M Buy
18,548
+611
+3% +$206K 0.02% 326
2019
Q3 		$4.97M Buy
17,937
+1,598
+10% +$473K 0.02% 351
2019
Q2 		$5.11M Sell
16,339
-763
-4% -$254K 0.02% 360
2019
Q1 		$7.02M Buy
17,102
+11,683
+216% +$4.81M 0.03% 327
2018
Q4 		$2.02M Sell
5,419
-1,409
-21% -$516K 0.01% 445
2018
Q3 		$2.76M Buy
6,828
+1,367
+25% +$520K 0.01% 446
2018
Q2 		$1.88M Sell
5,461
-113
-2% -$35.3K 0.01% 514
2018
Q1 		$1.92M Sell
5,574
-105
-2% -$36.5K 0.01% 489
2017
Q4 		$2.13M Sell
5,679
-2,284
-29% -$925K 0.01% 491
2017
Q3 		$3.56M Buy
+7,963
New +$3.79M 0.02% 386
2015
Q2 		– Sell
-17,374
Closed -$7.84M – 627
2015
Q1 		$7.84M Buy
17,374
+988
+6% +$419K 0.06% 235
2014
Q4 		$6.72M Sell
16,386
-70
-0.4% -$27.5K 0.05% 249
2014
Q3 		$5.93M Buy
16,456
+503
+3% +$169K 0.05% 262
2014
Q2 		$4.51M Sell
15,953
-134
-0.8% -$39.7K 0.04% 285
2014
Q1 		$4.94M Buy
+16,087
New +$4.96M 0.04% 269

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CIBC Private Wealth Group's REGN Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Regeneron Pharmaceuticals (REGN) stake by 8% in Q4 2025, selling an estimated $115K and leaving 1,943 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #640.

CIBC Private Wealth Group first reported a position in REGN in Q1 2014 and has held it in 39 quarters since. The position peaked at $12.1M in Q3 2020. 1,386 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • CIBC Private Wealth Group held 1,943 shares of Regeneron Pharmaceuticals worth $1.5M as of Q4 2025.
  • CIBC Private Wealth Group sold 170 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $115K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #640 holding.
  • CIBC Private Wealth Group first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 39 quarters since.
  • CIBC Private Wealth Group's Regeneron Pharmaceuticals position peaked at $12.1M in Q3 2020.
  • 1,386 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.